📚 PASS Research Analyst Certification Examination Difficulty: Beginner ℹ️ Info   ~5 min read
📌 Chapter 9.3 — Rights Issue

Imagine you are reviewing the quarterly performance of a mid-cap pharmaceutical company. Your valuation model suggests a steady earnings growth trajectory, but suddenly, the board announces a rights issue to fund a new manufacturing facility. As an analyst, your immediate task is to update your Earnings Per Share (EPS) projections. You are no longer just looking at the numerator—the profit—but are forced to adjust the denominator: the total number of outstanding shares.

This shift is the essence of equity dilution, a mechanical process that can fundamentally alter the perceived value of your client’s holdings.

When a company issues new shares, the total profit is spread across a larger pool of ownership. If the fresh capital does not immediately generate returns that exceed the dilution cost, the EPS will logically decline. In your financial model, you must calculate the ’theoretical ex-rights price’ to ensure your valuation remains accurate.

Failure to account for the increased share count often leads to an inflated price target, as the model continues to assume a smaller base of shares than what is currently active in the market. This is where the quality of your research earns its keep; you must determine if the capital expenditure will drive future earnings accretion or if it serves as a temporary band-aid that permanently thins the profit per share.

Consider a case where a company with an EPS of INR 10 executes a 1-for-4 rights issue. If you ignore the 25% increase in the denominator, you will drastically overestimate the future yield for your clients. By normalizing the share count—adjusting for the bonus element inherent in discounted rights issues—you gain clarity on whether the company’s capital allocation is truly value-additive.

This adjustment is not merely a bookkeeping exercise; it is a critical diagnostic of management’s ability to deploy cash efficiently. If the projected return on invested capital (ROIC) from the new project is lower than the cost of equity, the dilution acts as a double-edged sword: increasing the share count while dragging down the company’s profitability ratios.

Nuance

⚠️ Nuance
Many candidates incorrectly assume that dilution always implies a loss of shareholder value. In reality, if the capital raised is deployed into projects with returns higher than the cost of equity, the EPS may drop initially but increase in the long run. The true professional pitfall is focusing solely on the immediate dilution without projecting the asset base expansion, which can lead to a premature ‘sell’ recommendation on a stock that is actually positioning itself for superior future growth.

Check Your Understanding

Practice Question 1

Company X has 1,000,000 shares outstanding and reports a net profit of INR 50 million. It announces a 1-for-4 rights issue at a price significantly below current market value. Assuming the profit remains constant for the next period, what is the primary impact on the company’s EPS?

Practice Question 2

Which factor is most critical for a research analyst to evaluate when determining if an equity-diluting rights issue will be beneficial to shareholders over the long term?

This is a companion read for Section 9.3 — Rights Issue from PASS Research Analyst Certification Examination by Akhilesh Gururani, available on Amazon Kindle.

Copyright © 2026 Akhilesh Gururani. All rights reserved.